Alcami enhances analytical services in Edison, NJ

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Ca-ssis)
(Image: iStock/Ca-ssis)
The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

The CDMO offers comprehensive chemistry, environmental, and microbial capabilities at the facilities, in addition to multi-compendial testing and customized analysis.

According to the company, the Edison site is capable of meeting FDA requirements for Antibiotic Analysis both using USP < 81 > and can perform bridging analysis to an alternative method per USP < 1223.1 >. 

Additionally, Alcami has added​ 2,000 cubic feet of stability chamber space across its network, new control systems for all chambers, and a REES environmental monitoring system.

The company is also working to adopt Lean principles at its laboratories, a process which is said will be completed in 2017.

Alcami did not respond to a request for comment.

Related news

Show more

Related products

show more


Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Related suppliers

Follow us


View more